Bright Horizons Family Solutions, Inc. (NYSE:BFAM) shares advanced 1.56% in last trading session and ended the day at $68.37. BFAM Gross Margin is 24.40% and its has a return on assets of 4.10%. Bright Horizons Family Solutions, Inc. (NYSE:BFAM) quarterly performance is 7.35%.
Bright Horizons Family Solutions (NYSE:BFAM) announced that Stephen Kramer has been named President, effective January 1, 2016. Kramer currently serves as Bright Horizons’ Chief Development Officer and joined Bright Horizons in 2006 when the company acquired the organization he co-founded in 1998. He has previously served as Bright Horizons’ Managing Director for Europe and as Senior Vice President of Strategic Operations.
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) ended the last trading day at $0.42. Company weekly volatility is calculated as 17.80% and price to cash ratio as 64.40. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) showed a weekly performance of -9.57%.
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) announced that the Company has decided to postpone the Annual Meeting of Shareholders (the “Annual Meeting”) for lack of quorum to conduct business at the Annual Meeting. The Annual Meeting was originally scheduled to be held December 4, 2015, at the Company’s offices in Xianyang City, Shaanxi Province, PRC. The Company will notify shareholders of the new record date and meeting date and will send new proxy materials in the near term. Shareholders should note that the record date of the Annual Meeting will change.
On 29 December, Regal Entertainment Group (NYSE:RGC) shares advanced 0.64% and was closed at $18.77. RGC EPS growth in last 5 year was 1.90%. Regal Entertainment Group (NYSE:RGC) year to date (YTD) performance is -8.25%.
Regal Entertainment Group (NYSE:RGC) was upgraded by research analysts at S&P Equity Research from a “hold” rating to a “buy” rating in a report issued on Thursday, StockTargetPrices.com reports. The firm currently has a $16.00 price objective on the stock, up from their prior price objective of $15.00. S&P Equity Research’s price target would suggest a potential downside of 15.12% from the company’s previous close.
eMagin Corp. (NYSEMKT:EMAN) shares fell -3.52% in last trading session and ended the day at $1.37. EMAN Gross Margin is -3.52% and its has a return on assets of -24.23%. eMagin Corp. (NYSEMKT:EMAN) quarterly performance is -40.95%.
On 18 December, eMagin Corporation (NYSE MKT:EMAN), announced that it entered into a definitive securities purchase agreement with certain investors providing for the issuance, in a registered direct offering, of approximately $6,000,000 of common stock at a price per share of $1.50 and five and one half year warrants to purchase up to 2,600,000 shares of common stock at an exercise price of $2.05. The warrants will become exercisable six months from the date of the closing of the offering.
PTC Therapeutics, Inc. (NASDAQ:PTCT) caters to the Healthcare space. Its weekly performance is 1.57%. On the last day of trading company shares ended up at $33.54. PTC Therapeutics, Inc. (NASDAQ:PTCT) distance from 50-day simple moving average (SMA50) is 15.71%.
PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that the company will present a company overview at the upcoming 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at 9:30 am PT.
Leave a Reply